Serikawa Masahiro, Sasaki Tamito, Fujimoto Yoshifumi, Kuwahara Kenichi, Chayama Kazuaki
Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biochemical Research, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
J Clin Gastroenterol. 2006 Oct;40(9):856-62. doi: 10.1097/01.mcg.0000225609.63975.6f.
The aim of this study was to examine and clarify the preoperative markers that are useful for differentiating between benign and malignant lesions of intraductal papillary-mucinous neoplasms (IPMN) of the pancreas, grouped according to morphologic classification.
There are various stages of pathology in IPMN, ranging from benign to malignant lesions. Although the determination of appropriate treatment guidelines to deal with IPMN is a critical issue, no such guidelines have been established.
One hundred twenty cases of IPMN were classified morphologically into either main or branch duct types. We compared the morphologic classification with histopathologic diagnosis using indicators of malignancy detected by imaging such as main duct diameter, the number and diameter of cysts, and the presence or absence of mural nodules. We also examined the usefulness of pancreatic juice cytology and measurement of telomerase activity as indicators of malignancy. Finally, we performed a survival analysis on the basis of morphologic classification to determine prognosis of IPMN.
Whereas a high incidence (64%) of malignant lesions was seen in main duct type IPMN, benign lesions were dominant (80.5%) in branch duct type IPMN. Survival analysis showed that the prognosis was significantly worse in main duct type than in branch duct type IPMN. The lesions were aggravated in all patients with main duct type who did not undergo resection, resulting in death due to progression of the pancreatic lesion. The incidence of mural nodules was a useful indicator in main duct type, whereas main duct diameter and incidence of mural nodules were useful indicators in branch duct type. Although pancreatic juice cytology showed a high accuracy rate with low sensitivity for determining malignancy, measurement of telomerase activity in this juice was very effective for differentiating between benign and malignant lesions.
The incidence of malignant lesions was extremely high in main duct type IPMN, indicating that surgery is required in all these patients. However, to determine whether surgery is indicated in branch duct type IPMN it is necessary to obtain an appropriate image diagnosis focusing on main duct diameter and mural nodules and also to carry out cytology and measurement of telomerase activity in samples of pancreatic juice.
本研究旨在检查并阐明术前标志物,这些标志物有助于根据形态学分类区分胰腺导管内乳头状黏液性肿瘤(IPMN)的良性和恶性病变。
IPMN存在从良性到恶性病变的各种病理阶段。尽管确定处理IPMN的适当治疗指南是一个关键问题,但尚未建立此类指南。
120例IPMN病例按形态学分为主胰管型或分支胰管型。我们使用影像学检测到的恶性指标,如主胰管直径、囊肿数量和直径以及壁结节的有无,将形态学分类与组织病理学诊断进行比较。我们还检查了胰液细胞学检查和端粒酶活性测量作为恶性指标的有用性。最后,我们根据形态学分类进行生存分析以确定IPMN的预后。
主胰管型IPMN中恶性病变的发生率较高(64%),而分支胰管型IPMN中良性病变占主导(80.5%)。生存分析表明,主胰管型IPMN的预后明显比分支胰管型差。所有未接受切除的主胰管型患者的病变均加重,导致因胰腺病变进展而死亡。壁结节的发生率在主胰管型中是一个有用的指标,而主胰管直径和壁结节的发生率在分支胰管型中是有用的指标。尽管胰液细胞学检查在确定恶性方面显示出高准确率但敏感性低,但该胰液中端粒酶活性的测量对于区分良性和恶性病变非常有效。
主胰管型IPMN中恶性病变的发生率极高,表明所有这些患者都需要手术。然而,要确定分支胰管型IPMN是否需要手术,有必要获得以主胰管直径和壁结节为重点的适当影像诊断,并对胰液样本进行细胞学检查和端粒酶活性测量。